Wegovy has become one of the most talked-about weight-loss drugs in America. Millions of people have taken it hoping to lose weight and improve their health. But a growing number of patients say the drug caused severe, life-altering side effects they were never properly warned about — and lawsuits are now being filed across the country. If you took Wegovy and suffered serious harm, you may be entitled to compensation. This guide explains the Wegovy lawsuits, the side effects at the center of the litigation, what your claim could be worth, and how to file.
What Is Wegovy?
Wegovy is the brand name for semaglutide, a once-weekly injectable medication manufactured by Novo Nordisk. It was approved by the U.S. Food and Drug Administration (FDA) in June 2021 for chronic weight management in adults with obesity or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
Wegovy belongs to a class of drugs called GLP-1 receptor agonists. It mimics a hormone called glucagon-like peptide-1, which regulates appetite and blood sugar. The drug slows gastric emptying — meaning food stays in the stomach longer — which helps people feel full and eat less. The same mechanism, however, is at the heart of the lawsuits: when gastric emptying slows too much, patients can develop gastroparesis (stomach paralysis) and other severe gastrointestinal injuries.
Semaglutide is also sold under other brand names: Ozempic (for type 2 diabetes) and Rybelsus (an oral tablet). Because the active ingredient is the same, many of the legal claims involving Wegovy overlap with claims involving Ozempic and other GLP-1 drugs, and some are being litigated together in consolidated federal proceedings.
The Wegovy Lawsuits: What Are Plaintiffs Alleging?
The core allegation in Wegovy lawsuits is failure to warn. Plaintiffs claim that Novo Nordisk knew — or should have known — that semaglutide could cause severe gastrointestinal injuries, including gastroparesis, intestinal blockage, and related complications, but failed to adequately warn patients and doctors about those risks.
Specifically, lawsuits generally allege:
- Failure to warn: The drug's label and marketing materials did not adequately disclose the risk of gastroparesis, intestinal obstruction, ileus, and other severe gastrointestinal injuries.
- Defective design: The drug's design — which deliberately slows gastric emptying — is unreasonably dangerous when the risks outweigh the benefits for some patients.
- Negligent marketing: The manufacturer aggressively promoted Wegovy for weight loss, including off-label and cosmetic uses, without sufficiently communicating the severity of potential side effects.
- Failure to conduct adequate testing: Plaintiffs argue that pre-market clinical trials did not fully capture the frequency or severity of long-term gastrointestinal harms.
Novo Nordisk has defended its products, stating that the drugs were tested in extensive clinical trials, that the labels include warnings about gastrointestinal side effects, and that the benefits outweigh the risks for most patients. Whether the warnings were adequate is a central question the courts will decide.
GLP-1 Litigation and the Federal MDL
Many Wegovy and Ozempic lawsuits have been consolidated into a federal multidistrict litigation (MDL). An MDL groups similar cases before a single judge for pretrial proceedings — discovery, expert testimony, and early "bellwether" trials — while each plaintiff keeps an individual claim. Consolidation makes the litigation more efficient and often accelerates settlement negotiations.
In an MDL, the outcome of bellwether trials can strongly influence settlement values. If early trials result in large verdicts for plaintiffs, the manufacturer may be more motivated to settle remaining cases. If the manufacturer wins early trials, settlement offers may be lower. As of 2026, the GLP-1 litigation is still developing, and no global settlement has been announced — which means filing sooner rather than later can matter for preserving your rights.
Serious Side Effects Linked to Wegovy
All medications carry risks, and mild gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation are well known with GLP-1 drugs. The lawsuits focus on severe side effects that plaintiffs say were downplayed:
1. Gastroparesis (Stomach Paralysis)
Gastroparesis occurs when the stomach muscles slow down or stop working, so food remains in the stomach far longer than normal. Symptoms include severe nausea, vomiting (sometimes of undigested food eaten hours or days earlier), abdominal pain, bloating, loss of appetite, weight loss, and malnutrition. In severe cases, gastroparesis can be permanent and may require dietary changes, medication, a feeding tube, or surgery. Plaintiffs allege that Wegovy can cause or worsen gastroparesis and that the label did not clearly warn that the condition could be severe or irreversible.
2. Intestinal Blockage and Ileus
An intestinal blockage (bowel obstruction) occurs when food, fluid, or gas cannot pass through the intestines. Ileus is a temporary paralysis of the intestines that produces a similar effect. Symptoms include severe abdominal pain and cramping, bloating, vomiting, inability to pass gas or stool, and dehydration. A complete blockage is a medical emergency that can require hospitalization, nasogastric tubes, or surgery — and can be fatal if untreated.
3. Pancreatitis
Pancreatitis is inflammation of the pancreas. Acute pancreatitis causes sudden, severe upper abdominal pain (often radiating to the back), nausea, vomiting, fever, and rapid pulse. Severe cases can cause organ failure and death. The Wegovy label includes a warning about pancreatitis, but plaintiffs argue the risk was not emphasized strongly enough relative to how the drug was marketed.
4. Gallbladder Disease
Rapid weight loss itself increases gallbladder risk, and GLP-1 drugs have been associated with gallstones, gallbladder inflammation (cholecystitis), and gallbladder removal surgery. Symptoms include pain in the upper right abdomen, nausea, vomiting, fever, and jaundice. Many plaintiffs who needed gallbladder surgery after taking Wegovy have joined the litigation.
5. Vision Loss (NAION)
More recently, researchers have investigated a possible link between semaglutide and non-arteritic anterior ischemic optic neuropathy (NAION), a condition that causes sudden vision loss in one eye due to reduced blood flow to the optic nerve. The evidence is still evolving, and regulators have asked for further study. Some lawsuits have begun to include vision-loss claims, though they are not the central focus of the current MDL.
6. Severe Dehydration and Malnutrition
Persistent vomiting, diarrhea, and inability to eat can lead to severe dehydration, electrolyte imbalances, kidney injury, and malnutrition — particularly in older adults or patients with pre-existing conditions. Hospitalization, IV fluids, and long-term nutritional support may be required.
Who Qualifies to File a Wegovy Lawsuit?
You may qualify to file a Wegovy lawsuit if you meet criteria similar to these:
- You were prescribed and took Wegovy (or another semaglutide product) for weight management or a related condition.
- You suffered a serious injury — such as gastroparesis, intestinal blockage, ileus, pancreatitis, gallbladder disease requiring surgery, or another severe gastrointestinal condition — after starting the drug.
- Your injury required medical treatment, hospitalization, surgery, or ongoing care.
- Your injury occurred within the applicable statute of limitations (see below).
- You can document your prescription and your injury through medical records.
Family members may also be able to file a wrongful death claim if a loved one died from a Wegovy-related injury. A qualified Wegovy lawyer can review your medical records — usually free of charge — and tell you whether your case meets the current filing criteria used by the MDL and state courts.
What Compensation Can You Recover?
Compensation in a Wegovy lawsuit can include:
- Medical expenses: Past and future costs of hospitalization, surgery, medications, specialist visits, feeding tubes, dietary management, and ongoing treatment.
- Lost wages: Income lost while you were unable to work, plus reduced earning capacity if your injury affects your ability to work long-term.
- Pain and suffering: Compensation for physical pain, emotional distress, anxiety, depression, and loss of enjoyment of life.
- Loss of consortium: Compensation for the impact of your injury on your relationship with your spouse or family.
- Punitive damages: In cases where the manufacturer is found to have acted with reckless disregard for patient safety, courts may award punitive damages to punish the company and deter similar conduct. Punitive damages are rare and depend on state law.
- Wrongful death damages: If a loved one died, surviving family members may recover funeral expenses, loss of financial support, and loss of companionship.
Settlement Values in 2026: What Could a Wegovy Case Be Worth?
It is too early to predict exact settlement values because the litigation is still in its early phases and no global settlement has been finalized. However, based on comparable pharmaceutical mass-tort cases, attorneys generally expect settlement values to be tiered by injury severity:
- Lower tier: Cases involving temporary but serious gastrointestinal injuries that resolved with treatment may settle in the tens of thousands of dollars.
- Middle tier: Cases involving hospitalization, surgery (such as gallbladder removal), or prolonged treatment may settle in the range of $100,000 to $300,000.
- Higher tier: Cases involving permanent gastroparesis, multiple surgeries, feeding tubes, permanent disability, or wrongful death could reach $400,000 or more, depending on the evidence and jurisdiction.
These are estimates, not guarantees. Your actual recovery depends on the strength of your medical evidence, the severity and permanence of your injury, your economic losses, the jurisdiction where your case is filed, and whether the litigation settles globally or proceeds to individual trials. Be wary of any lawyer who promises a specific dollar amount before reviewing your records.
Lawsuit vs. Class Action vs. MDL: What's the Difference?
- Individual lawsuit: You file your own case. Your compensation is based on your specific injuries and losses.
- Class action: A large group of people with similar claims are treated as a single class, and any recovery is divided among class members — usually resulting in smaller individual payments. Class actions are uncommon for serious personal-injury claims like Wegovy cases.
- MDL (multidistrict litigation): Each plaintiff keeps an individual case, but pretrial proceedings are coordinated before one judge. Settlements in an MDL are typically negotiated individually or in tiers based on injury severity. Most Wegovy cases are proceeding through the MDL model.
How to File a Wegovy Lawsuit: 7 Steps
- Stop and get medical care first. If you are experiencing severe symptoms — persistent vomiting, severe abdominal pain, inability to pass stool, or signs of dehydration — seek emergency care immediately. Do not stop or continue any medication without talking to your doctor.
- Preserve your records. Gather your Wegovy prescription records, pharmacy records, dosage history, and all medical records related to your injury: ER visits, hospitalizations, imaging, diagnoses, surgeries, and follow-up care. Keep receipts for out-of-pocket costs and a log of missed work.
- Do not sign anything from the manufacturer or its insurer without legal advice. Early settlement offers in mass-tort cases are often far below what a case is worth.
- Contact a Wegovy lawyer for a free case evaluation. Most mass-tort attorneys work on contingency (see below) and will review your records at no cost.
- Your lawyer investigates and files your claim. Your attorney will gather medical evidence, consult medical experts, and file your complaint in the appropriate court or MDL.
- Discovery and expert review. Both sides exchange evidence. Your attorney may arrange for an expert to review your medical records and confirm that Wegovy more likely than not caused or contributed to your injury.
- Settlement or trial. Most mass-tort cases settle. If a fair settlement cannot be reached, your case may proceed to a bellwether or individual trial.
Statute of Limitations: Don't Wait
Every state sets a deadline — the statute of limitations — for filing a personal-injury lawsuit, typically 1 to 6 years from the date of injury or the date you discovered (or reasonably should have discovered) that the drug caused your injury. Some states apply a "discovery rule," which starts the clock when you first learn that Wegovy may have caused your condition rather than when you took the drug.
Because the deadlines vary widely and can be affected by when you were diagnosed, when you stopped taking the drug, and where you file, contact a lawyer as soon as possible. Missing the deadline can permanently bar your claim, even if your injury is severe.
How Much Does a Wegovy Lawyer Cost?
Almost all Wegovy lawyers work on a contingency fee basis: you pay nothing upfront, and the lawyer is paid a percentage (typically 33% to 40%) of any settlement or verdict you receive. If you recover nothing, you generally owe no attorney's fees. Ask your lawyer to explain the fee agreement in writing, including how case costs and expenses (such as expert reviews and filing fees) are handled.
Choosing the Right Wegovy Lawyer
- Mass-tort experience: Choose a firm that is actively litigating GLP-1 cases and participating in the MDL — not a generalist firm that will refer your case elsewhere.
- Medical expertise: The firm should have access to medical experts who understand gastroparesis, intestinal obstruction, and GLP-1 pharmacology.
- Clear communication: You should receive regular updates and honest answers about timelines and settlement prospects.
- No upfront fees: A reputable Wegovy lawyer will evaluate your case for free and work on contingency.
- Check the fine print: Make sure you understand who will actually handle your case, whether it will be filed in the MDL or state court, and how fees are calculated.
Common Mistakes to Avoid
- Waiting too long. Statutes of limitations can expire, and medical records become harder to obtain over time.
- Accepting a quick settlement from an insurer or claims administrator before knowing the full extent of your injury.
- Stopping medical treatment or failing to follow your doctor's recommendations — gaps in treatment can hurt both your health and your claim.
- Posting about your case on social media. Defense attorneys and insurers monitor public posts; avoid discussing your injuries, medications, or legal strategy online.
- Throwing away evidence: Keep prescription packaging, pharmacy receipts, and all medical bills.
- Assuming you can't file because you signed a consent form. A consent form does not excuse a manufacturer from its duty to provide adequate warnings.
Still Taking Wegovy? What Should You Do?
If you are currently taking Wegovy and experiencing concerning symptoms — persistent vomiting, severe abdominal pain, bloating that won't resolve, or inability to keep food down — contact your doctor promptly. Do not stop a prescribed medication without medical advice, but do tell your doctor about your symptoms and ask whether gastroparesis or another complication should be evaluated. Early diagnosis and treatment can improve outcomes and also creates the medical documentation that supports a legal claim if you later decide to file.
Frequently Asked Questions
Can I file if I took Ozempic instead of Wegovy?
Possibly. Because both drugs contain semaglutide, many of the same allegations apply. A lawyer can tell you whether your Ozempic case belongs in the same litigation or should be filed separately.
What if I only had mild nausea?
Mild, temporary side effects that resolved without medical treatment generally do not support a lawsuit. The current litigation focuses on severe injuries that required hospitalization, surgery, or ongoing care.
Will I have to go to court?
Probably not. Most mass-tort cases settle without a trial. Your lawyer will advise you if your case is selected as a bellwether trial case.
How long does a Wegovy lawsuit take?
Mass-tort cases often take 1 to 3 years or longer from filing to resolution, depending on the MDL schedule, bellwether trials, and settlement negotiations.
Does the FDA approval of Wegovy prevent lawsuits?
No. FDA approval does not shield a manufacturer from failure-to-warn claims if the label is found to have inadequately disclosed known risks.
The Bottom Line
Wegovy has helped many people lose weight, but for some patients the drug has caused severe gastrointestinal injuries that required hospitalization, surgery, or lifelong management. Lawsuits allege that Novo Nordisk failed to adequately warn patients about those risks. If you took Wegovy and suffered a serious injury — especially gastroparesis, intestinal blockage, pancreatitis, or gallbladder disease requiring surgery — you may have a claim. Talk to an experienced Wegovy lawyer for a free evaluation, preserve your medical records, and act before your state's statute of limitations expires. You pay nothing upfront, and you may be entitled to compensation for your medical bills, lost income, and suffering.
Disclaimer: Informational only, not legal advice. Consult a licensed attorney in your state. Settlement values are estimates based on comparable litigation and are not guarantees.
